Written answers

Tuesday, 17 July 2012

Department of Justice, Equality and Defence

Defence Forces Medicinal Products

8:00 pm

Photo of Aengus Ó SnodaighAengus Ó Snodaigh (Dublin South Central, Sinn Fein)
Link to this: Individually | In context

Question 622: To ask the Minister for Defence the number of Doxycycline tablets issued to members of the Defence Forces annually since 2000. [34872/12]

Photo of Alan ShatterAlan Shatter (Dublin South, Fine Gael)
Link to this: Individually | In context

I am informed by the Military Authorities that a total of 27,392 Doxycycline capsules were purchased by the Brigade Medical Services (BMS) since 2006. The Military Authorities have advised that BMS records are only available from 2006 onwards. A breakdown is provided in the following table.

Year/ Dosage2006200720082009201020112012
100mg48005600-800040002003840
50mg56------
20mg---896---
Total48565600-889640002003840

Grand total of Doxycycline tablets purchased by the BMS from 2006 to 2012: 27,392.

Doxycycline is licensed for use by the Irish Medicine Board. The choice of chemoprophylaxis medication depends on the risk of malaria in the destination, resistance to particular drugs, the profile of the traveller (contra-indications, underlying health conditions, purpose of travel), the duration of travel and finally adherence issues. Doxycycline has to be taken in the absence of dairy products. It has a daily dosage regime. While it can cause minor but troublesome, mainly gastrointestinal side effects, it can also produce sun-sensitivity skin rashes (akin to severe sun burn) in some individuals. This is particularly significant when used in very sunny climes. For this reason it is not recommended for first line use by the Defence Forces in sub-Saharan Africa. It is the anti-malaria chemoprophylaxis of first choice by the Defence Forces in some geographic regions, e.g. Afghanistan. Information is currently being compiled on the number of tablets issued and I will forward this collated information to the Deputy when it becomes available.

Comments

No comments

Log in or join to post a public comment.